Endotoxin, epinephrine, and ellagic acid effects on the radiation-sensitized walker 256 rat carcinosarcoma.
A radiation exposure of 1500 R to the Walker 256 rat tumor was found to sensitize this tumor to the effect of a sublethal dose of endotoxin (Sarratia marcescens lipopolysaccharide) given 2 days later so that complete or almost complete destruction of the tumor resulted. Histological. study showed rapidly developing massive necrosis of tumor tissue. Tracer experiments with 131I-labeled antibody to rat fibrin indicated an absence of blood circulation in the treated tumor. These results suggest that the lesion may be secondary to blood coagulation occurring in the vascular bed of the tumor. Apparently identical lesions were also produced by epinephrine and ellagic acid, alone or in combination. It is known that even untreated tumors are often the site of fibrin deposition. Presumably radiation, by injury to tumor cells, enhances the release of coagulation-producing substances into the vascular bed. It is postulated that the effect of subsequent treatment with the drugs listed above is produced by circulatory stasis induced in the tumor. This may be associated with Hageman factor activation or release of platelet factor 3.
Contreras
M D
MD
Department of Radiation Biology and Biophysics, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA.
Bale
W F
WF
D000818:Animals; D002277:Carcinoma / Q000188:drug therapy* / Q000473:pathology* / Q000532:radiotherapy; D003131:Combined Modality Therapy; D004305:Dose-Response Relationship, Drug; D004610:Ellagic Acid / Q000008:administration & dosage*; D004731:Endotoxins / Q000008:administration & dosage*; D004837:Epinephrine / Q000008:administration & dosage*; D005260:Female; D011836:Radiation Tolerance / Q000187:drug effects*; D051381:Rats; D017207:Rats, Sprague-Dawley; D016896:Treatment Outcome
D004731:Endotoxins; D004610:Ellagic Acid; D004837:Epinephrine